EQS-News: LR Health & Beauty SE
/ Key word(s): Quarter Results
LR Health & Beauty SE delivers good start into the 2024 financial year
Ahlen, 28 May 2024 – LR Health & Beauty SE, Europe’s leading digital social selling company in the area of high-quality health and beauty products, today published its figures for the first quarter of 2024, according to which LR Health & Beauty SE generated sales (revenue from goods sold) of EUR 72.6 million (2022*: EUR 72.0 million). Despite unfavourable currency effects, the company thus achieved a slight increase in sales of around 0.8% compared to the first quarter of the previous year. In terms of earnings, LR Health & Beauty SE generated normalised EBITDA of EUR 7.8 million in the first three months of 2024, compared to EUR 8.7 million in the same period of the previous year. Earnings were impacted by the refinancing costs associated with the early redemption of the old bond of LR Global Holding GmbH and the issue of the new bond of LR Health & Beauty SE. EBITDA reported in the first quarter of 2024 was EUR 6.1 million, compared to EUR 7.8 million in the first quarter of 2023. Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations of the LR Group, comments: “All in all, LR has made a good start into the year 2024 and has achieved a sound performance in the important markets of Western and Eastern Europe. New product launches from previous periods, in particular the innovative BODY MISSION, made a significant contribution to growth in the first quarter. The success of our latest product launches once again validates our strategy.” Integrating AI to streamline social selling processes Dr Andreas Laabs, CEO of LR Health & Beauty SE, explains: “In 2024, we will continue to focus on the further digitalisation of our company and the use of innovative technologies to further optimise our business processes. We also strive to provide our partners with the best possible sales support through new product innovations. Our pipeline for this year includes both new products and seasonal sales promotions such as ‘Crazy Summer’. We’re also preparing the launch of a new product segment for the autumn of 2024, which will perfectly complement our product offering.” LR is placing great focus on the further digitalisation of its business processes. For example, through the Group’s digital platform LR neo, partners can now access a wide range of information relevant to their sales activities. The company has also developed its own chatbot: “LR-Vera” is designed to support efficient customer service. The chatbot enables customer service centre staff to access a centralised knowledge pool that facilitates quick and comprehensive answers. Outlook 2024 LR Health & Beauty SE expects that it will continue to capitalise on the growth opportunities in the Health & Beauty segments and sees this confirmed by a further increase in momentum in the second quarter of the year. Based on conservative assumptions, LR continues to expect sales at the previous year’s level and an only slightly lower or stable EBITDA for the 2024 financial year. The full report for the first quarter of 2024 is available online from today on the company website at https://ir.lrworld.com/ *As issuer of the New Bond 2024/2028, LR Health & Beauty SE discloses the figures for the first quarter of 2024 and for the first quarter of the previous year 2023. The previous year’s figures for 2023 may differ from the figures for 2023 disclosed previously by LR Global Holding GmbH. Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality health and beauty products in 32 countries. As an attractive social selling company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence. The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. LR currently has around 1,200 employees and hundreds of thousands of registered community members. PR Contact: LR Health & Beauty SE
cometis AG
28.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | LR Health & Beauty SE |
Kruppstr. 55 | |
59227 Ahlen | |
Germany | |
Phone: | +49 238270600 |
E-mail: | info@lrworld.com |
Internet: | www.lrworld.com |
ISIN: | NO0013149658 |
WKN: | A3H3FM |
Listed: | Regulated Unofficial Market in Frankfurt; Stockholm |
EQS News ID: | 1912045 |
End of News | EQS News Service |
|
1912045 28.05.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.